Navigation Links
Agenda Announced for the 2014 Drug and Medical Device Litigation

NEW YORK, Sept. 3, 2014 /PRNewswire/ -- American Conference Institute (ACI) is pleased to announce the agenda for its 19th Annual Drug and Medical Device Litigation on December 8-10 in New York City. Agenda is now available online.

Photo -

Featuring 3 new Co-Chairs:
Sonia Arnold
Counsel-Litigation and Legal Compliance, Eli Lilly and Company (Indianapolis, IN)

Max Heerman
Principal Litigation Counsel, Medtronic, Inc. (Minneapolis, MN)

Malini Moorthy
Head of U.S. Litigation, Bayer (Pittsburgh, PA)

FDA Keynote on Generic Labeling and Preemption:
Kelsey Schaefer (Invited)
Associate Chief Counsel for Enforcement, FDA

View the full faculty list –

Our accomplished faculty and our new Drug and Med Advisory Board— a veritable "Who's Who" of the products liability defense bar — have united to refresh this year's agenda and will provide comprehensive updates and in-depth analysis of the year's biggest legal developments in key sessions on:

  • Discovery best practices post-Actos
  • Defending against creative attempts to defeat CAFA removal
  • The continuing battle over generic preemption and medical device preemption post-Stengel
  • Using third parties to fund drug and med litigation and much more...

Reacting to this year's faculty and program content, Drug and Med Advisory Board members remarked:

"As always, I am impressed with the range and depth of the presenters.  There is no better forum for leading edge thinking on today's most pressing drug and med litigation challenges."
Patrick L. Gibson, Director, Government Investigations, Merck & Co

"The ACI Drug and Med conference is a great opportunity to connect with other members of the products liability bar and get real-time and real-world information about  mass tort litigation throughout the country.  This year's program features new sessions on the year's biggest developments including e-discovery best practices, creative attempts by members of the plaintiffs' bar to defeat CAFA, and updates on preemption."
Debra L. Burns, Senior Counsel Litigation / Investigations, GE Healthcare

About ACI - American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.

Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.

Contact: Linda Lam
Phone: 212-352-3220 ext. 5538

SOURCE American Conference Institute
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Quality Metrics Conference Shapes PDA Metrics Agenda
2. New Addition to the Prostate Cancer Roundtable Policy Agenda Addresses Quality-of-Life Endpoints
3. Forschungsbasierte Pharmaindustrie fordert ein verstärktes Engagement seitens des öffentlich-privaten Sektors, um die Millennium-Entwicklungsziele (MDGs) schneller zu erreichen und um eine neue Entwicklungsagenda aufzustellen
4. Research-based Pharmaceutical Industry Calls for Public-Private Sector Engagement to Accelerate Progress Towards the Millennium Development Goals (MDGs) and in Planning New Development Agenda
5. Sanraku Hospital, Wake Forest Baptist Medical Center Added to RFID in Health Care 2013 Agenda
6. Comprehensive Care Corporation CEO Clark A. Marcus Named to Board of Americas Agenda: Health Care for All
7. $150,000 Donation from Long-Time Supporter of Mesothelioma Research Helps Support The Pacific Meso Centers 2013 Agenda
8. PCMA: New Report Shows Drugstore Lobby Agenda Raises Rx Costs for Small Businesses, Government Programs
9. Safe in Commons "The Unfinished Agenda: Addressing the Challenges" Crystalizes Call for Unified Protection Against Needlestick and Sharps Injuries
10. Detailed Programmes and Agendas Available for American and International Health Care Forums
11. Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, ... optimizing treatment outcomes for patients suffering from chronic pain, ... for a Temporary Restraining Order (TRO) enjoining Express Scripts ... two companies. --> --> ... all of its legal options. --> ...
(Date:11/25/2015)... AVIV, Israel , November 25, 2015 ... (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company ... simultaneous treatment of various clinical conditions, today announced the ... 3,158,900 American Depository Shares ( ADSs ), each representing ... purchase up to 3,158,900 ADSs. The ADSs and warrants ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 Endo International ... Rajiv De Silva , President and CEO, will discuss ... Healthcare Conference in New York on ... . Click on Investor Relations, and then the ... prior to the presentation,s start time to visit the site ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new Android app ... new app features a more intuitive SleepScore™ that rates sleep quality on a 100-point ... SleepScore is created by a proprietary algorithm. Beddit analyzes the data to provide an ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
(Date:11/25/2015)... ... , ... Today, Mothers Against Drunk Driving (MADD) learned that the ... the first time since 2011. In 2014, there were 9,967 fatalities involving an alcohol ... National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in ...
(Date:11/25/2015)... ... November 25, 2015 , ... In ... nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension ... Pioneers, nominated by the public, will receive special recognition throughout 2016 as part ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract Development ... expansion of its current state of the art research, development and manufacturing facility ... increase its manufacturing capacity as well as to support its clients’ growing research ...
Breaking Medicine News(10 mins):